Kazuyoshi Kuwano - Concepedia

Author

Kazuyoshi Kuwano

Jikei University School of Medicine

Also Known As

K Kuwano, K. Kuwano, KAZUYOSHI KUWANO, Kazuyoshi KUWANO, Kazuyoshi Kuwano, Kuwano K, Kuwano, Kazuyoshi, M. Ichiki

122

Publications

3.8K

Citations

H-Index

Concepts

All Affiliations

Jikei University School of Medicine Kyushu University Kanagawa Cardiovascular and Respiratory Center Tokyo National Hospital National Cancer Center Hospital East

About

Kazuyoshi Kuwano is an author at Jikei University School of Medicine specializing in medicine, pathology, and lung cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	13	1.2K
2	Cell Biology	4	4	918
3	Health Sciences	3	3	48
4	Allergy	1	1	344
5	Critical Care Medicine	1	1	12

Kazuyoshi Kuwano

Publications

3.5K

Citations

H-Index

Page 1

	Year	Citations
Small Airways Dimensions in Asthma and in Chronic Obstructive Pulmonary Disease Kazuyoshi Kuwano, Carol H. Bosken, Peter D. Paré, American Review of Respiratory Disease	1993	583
Functional significance of increased airway smooth muscle in asthma and COPD R. K. Lambert, B. R. Wiggs, Kazuyoshi Kuwano, Journal of Applied Physiology	1993	473
Essential roles of the Fas-Fas ligand pathway in the development of pulmonary fibrosis Kazuyoshi Kuwano, Naoki Hagimoto, Masayuki Kawasaki, Journal of Clinical Investigation Acute Lung InjuryInflammatory Lung DiseaseAdvanced Lung DiseaseApoptosisImmunology	1999	344
P21Waf1/Cip1/Sdi1 and p53 expression in association with DNA strand breaks in idiopathic pulmonary fibrosis. Kazuyoshi Kuwano, Ritsuko Kunitake, M. Kawasaki, American Journal of Respiratory and Critical Care Medicine Inflammatory Lung DiseaseAdvanced Lung DiseaseLung InflammationApoptosisImmunology	1996	333
The Clinical Relevance of the miR-197/CKS1B/STAT3-mediated PD-L1 Network in Chemoresistant Non-small-cell Lung Cancer Yu Fujita, Shigehiro Yagishita, Keitaro Hagiwara, Molecular Therapy	2015	257
Soluble Programmed Cell Death Ligand 1 as a Novel Biomarker for Nivolumab Therapy for Non–Small-cell Lung Cancer Yusuke Okuma, Hiroshi Wakui, Hirofumi Utsumi, Clinical Lung Cancer Non–small-cell Lung CancerNivolumab TherapyMedicineImmunologyCell Death	2018	144
Endothelial Cell Apoptosis in Lipopolysaccharide–Induced Lung Injury in Mice Masaki Fujita, Kazuyoshi Kuwano, Ritsuko Kunitake, International Archives of Allergy and Immunology	1998	138
RNAi Therapeutic Platforms for Lung Diseases Yu Fujita, Fumitaka Takeshita, Kazuyoshi Kuwano, Pharmaceuticals Inflammatory Lung DiseaseNovel TherapyLung InflammationRna InterferenceRnai Delivery	2013	97
Final safety and efficacy of erlotinib in the phase 4 <scp>POLARSTAR</scp> surveillance study of 10 708 Japanese patients with non‐small‐cell lung cancer Akihiko Gemma, Shoji Kudoh, Masahiko Ando, Cancer Science Cancer RiskAdvanced Lung DiseasePhase 4Ild Risk FactorsMedicine	2014	83
Serum KL-6 and surfactant protein-D as monitoring and predictive markers of interstitial lung disease in patients with systemic sclerosis and mixed connective tissue disease Hideaki Yamakawa, Eri Hagiwara, Hideya Kitamura, Journal of Thoracic Disease	2017	68

Page 1